tiprankstipranks
Medico Remedies Ltd. (IN:MEDICO)
:MEDICO
India Market
MEDICO
Medico Remedies Ltd.
RESEARCH TOOLSreports

Medico Remedies Ltd. (MEDICO) Ratios

0 Followers

Medico Remedies Ltd. Ratios

IN:MEDICO's free cash flow for Q2 2026 was ₹0.23. For the 2026 fiscal year, IN:MEDICO's free cash flow was decreased by ₹ and operating cash flow was ₹0.07. See a summary of the company’s cash flow.
Ratios
TTM
Mar 25Mar 24Mar 23Mar 22
Liquidity Ratios
Current Ratio
 1.62 1.70 1.72 1.55 1.51
Quick Ratio
 1.03 1.23 1.34 1.07 1.03
Cash Ratio
 <0.01 0.02 <0.01 0.02 0.03
Solvency Ratio
 0.21 0.23 0.32 0.23 0.18
Operating Cash Flow Ratio
 <0.01 0.09 0.06 0.20 0.04
Short-Term Operating Cash Flow Coverage
 0.05 0.35 0.40 1.01 0.18
Net Current Asset Value
₹ 432.98M₹ 393.45M₹ 299.40M₹ 209.34M₹ 187.03M
Leverage Ratios
Debt-to-Assets Ratio
 0.09 0.12 0.08 0.11 0.17
Debt-to-Equity Ratio
 0.19 0.24 0.15 0.22 0.34
Debt-to-Capital Ratio
 0.16 0.19 0.13 0.18 0.25
Long-Term Debt-to-Capital Ratio
 0.00 0.00 0.00 0.00 0.02
Financial Leverage Ratio
 2.05 1.92 1.84 1.99 2.04
Debt Service Coverage Ratio
 1.13 0.77 1.94 1.21 0.74
Interest Coverage Ratio
 14.28 31.36 12.34 9.35 8.25
Debt to Market Cap
 0.04 0.03 0.02 0.01 0.05
Interest Debt Per Share
 1.68 1.92 1.07 1.27 1.59
Net Debt to EBITDA
 0.65 0.91 0.44 0.65 1.22
Profitability Margins
Gross Profit Margin
25.51%28.23%12.09%25.33%14.60%
EBIT Margin
8.31%7.93%8.26%7.72%5.88%
EBITDA Margin
9.91%9.94%12.24%9.66%7.71%
Operating Profit Margin
10.45%24.07%7.01%4.97%4.31%
Pretax Profit Margin
8.09%8.95%7.82%7.19%5.36%
Net Profit Margin
6.08%6.69%5.72%5.16%3.98%
Continuous Operations Profit Margin
6.08%6.69%5.72%5.16%3.98%
Net Income Per EBT
75.13%74.74%73.14%71.71%74.22%
EBT Per EBIT
77.43%37.16%111.50%144.60%124.30%
Return on Assets (ROA)
8.44%8.43%8.62%8.28%6.32%
Return on Equity (ROE)
18.76%16.16%15.83%16.52%12.89%
Return on Capital Employed (ROCE)
29.78%57.82%19.04%15.29%13.71%
Return on Invested Capital (ROIC)
18.87%35.19%12.28%9.25%8.22%
Return on Tangible Assets
8.45%8.43%8.63%8.29%6.32%
Earnings Yield
3.66%2.29%2.02%1.16%2.39%
Efficiency Ratios
Receivables Turnover
 3.31 2.64 2.92 3.89 3.95
Payables Turnover
 2.65 3.12 4.04 3.38 3.53
Inventory Turnover
 3.44 4.05 7.80 5.32 5.29
Fixed Asset Turnover
 8.98 6.99 6.78 6.43 7.52
Asset Turnover
 1.39 1.26 1.51 1.61 1.59
Working Capital Turnover Ratio
 8.80 4.27 5.40 6.66 6.05
Cash Conversion Cycle
 78.87 111.36 81.53 54.53 58.20
Days of Sales Outstanding
 110.25 138.27 125.01 93.81 92.47
Days of Inventory Outstanding
 106.24 90.05 46.81 68.56 69.06
Days of Payables Outstanding
 137.62 116.96 90.28 107.84 103.33
Operating Cycle
 216.49 228.32 171.81 162.37 161.53
Cash Flow Ratios
Operating Cash Flow Per Share
 0.08 0.59 0.32 0.98 0.21
Free Cash Flow Per Share
 -0.07 0.21 0.02 0.19 -0.14
CapEx Per Share
 0.15 0.38 0.30 0.79 0.34
Free Cash Flow to Operating Cash Flow
 -0.91 0.35 0.08 0.19 -0.67
Dividend Paid and CapEx Coverage Ratio
 0.52 1.54 1.08 1.24 0.60
Capital Expenditure Coverage Ratio
 0.52 1.54 1.08 1.24 0.60
Operating Cash Flow Coverage Ratio
 0.05 0.33 0.33 0.84 0.14
Operating Cash Flow to Sales Ratio
 <0.01 0.03 0.02 0.06 0.01
Free Cash Flow Yield
-0.18%0.39%0.05%0.25%-0.57%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 27.32 43.69 49.45 86.00 41.85
Price-to-Sales (P/S) Ratio
 1.66 2.92 2.83 4.43 1.66
Price-to-Book (P/B) Ratio
 4.74 7.06 7.83 14.21 5.40
Price-to-Free Cash Flow (P/FCF) Ratio
 -541.00 258.26 2.01K 395.45 -175.10
Price-to-Operating Cash Flow Ratio
 492.87 90.14 152.83 76.26 117.76
Price-to-Earnings Growth (PEG) Ratio
 12.48 1.99 3.31 1.72 0.48
Price-to-Fair Value
 4.74 7.06 7.83 14.21 5.40
Enterprise Value Multiple
 17.40 30.30 23.56 46.56 22.80
Enterprise Value
 3.29B 4.55B 4.18B 6.32B 2.13B
EV to EBITDA
 17.40 30.30 23.56 46.56 22.80
EV to Sales
 1.72 3.01 2.88 4.50 1.76
EV to Free Cash Flow
 -561.93 266.23 2.04K 401.07 -185.04
EV to Operating Cash Flow
 511.94 92.92 155.76 77.34 124.44
Tangible Book Value Per Share
 8.05 7.54 6.30 5.27 4.49
Shareholders’ Equity Per Share
 8.06 7.55 6.32 5.28 4.49
Tax and Other Ratios
Effective Tax Rate
 0.25 0.25 0.27 0.28 0.26
Revenue Per Share
 23.00 18.24 17.48 16.92 14.54
Net Income Per Share
 1.40 1.22 1.00 0.87 0.58
Tax Burden
 0.75 0.75 0.73 0.72 0.74
Interest Burden
 0.97 1.13 0.95 0.93 0.91
Research & Development to Revenue
 0.00 0.00 0.00 0.00 0.00
SG&A to Revenue
 0.05 0.07 0.04 0.02 0.02
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.05 0.48 0.32 1.13 0.35
Currency in INR